
Historic Executive Order: Federal Ibogaine Research for Veterans
President Trump signs landmark directive directing $50M+ in federal funding to accelerate ibogaine clinical development for veterans with PTSD and TBI.
Read More →Championing ibogaine-assisted therapy as a breakthrough treatment for PTSD, traumatic brain injury, and addiction — when Israel needs it most.
Israelis currently receiving treatment for war-related psychological trauma
President Trump signs landmark directive directing $50M+ in federal funding to accelerate ibogaine clinical development for veterans with PTSD and TBI.
הנשיא טרמפ חתם על צו נשיאותי היסטורי המקצה למעלה מ-50 מיליון דולר למחקר האיבוגאין — פריצת דרך ענקית לטיפול ב-PTSD ופגיעות ראש טראומטיות בוותיקי צבא.
Read Full Article →
The website brand name may differ from the legal registered entity name. All operations, activities, and services are conducted under the registered amutah listed above.

President Trump signs landmark directive directing $50M+ in federal funding to accelerate ibogaine clinical development for veterans with PTSD and TBI.
Read More →
Ynet's Dr. Roy Zucker examines ibogaine's extraordinary promise for addiction and PTSD — and the cardiac risks and regulatory hurdles that keep Big Pharma at bay. Plus: the Israeli firm PsyRx taking a safer microdose path.
Read More →
A peer-reviewed study published in Nature Medicine confirms ibogaine's extraordinary efficacy for traumatic brain injury and PTSD. Here's what it means for Israel.
Read More →
The iboga plant has been sacred to Bwiti communities for centuries. We trace the journey from Central African rainforests to modern psychiatric clinics.
Read More →
With 85,000 soldiers receiving psychological treatment and therapist shortages reaching crisis levels, conventional approaches are falling short.
Read More →
Ibogaine's ability to stimulate GDNF — a key neurotrophic factor for dopamine neurons — is opening new possibilities for neurodegenerative disease treatment.
Read More →
As Texas allocates $50 million for ibogaine clinical trials, Israel must move swiftly to ensure its trauma survivors have access to the world's most promising new therapy.
Read More →
In 1962, a 19-year-old heroin addict named Howard Lotsof took ibogaine and woke up free. His life's work created the global ibogaine treatment movement.
Read More →Explore curated podcasts, interviews, and videos about ibogaine from leading experts, advocates, and survivors.
Former U.S. Secretary of Energy Rick Perry and Americans for Ibogaine CEO W. Bryan Hubbard discuss policy, veteran access, and the legislative push for ibogaine clinical research.
Listen NowA deep-dive conversation exploring the growing awareness of ibogaine, featuring advocacy insights and the personal healing journey of former NFL player Robert Gallery.
Listen NowA featured panel from South by Southwest (SXSW) exploring ibogaine's transition from the underground to a highly researched clinical tool for addressing modern mental health crises.
A powerful short feature profiling former NFL offensive lineman Robert Gallery, his struggle with the long-term effects of repeated head trauma (TBI), and his recovery following ibogaine treatment.
Israeli policy pioneer and ibogaine advocate Boaz Wachtel on iboga’s traditional roots, decades of clinical experience with addiction interruption, and the push for evidence-based access and research.
In-depth late-night interview with foundation co-founder Boaz Wachtel on Israel’s mainstream Channel 12, with hosts Avri Gilad and Yaakov Sharki — covering ibogaine as a potential breakthrough for PTSD, traumatic brain injury and addiction, and the push for research and access in Israel. Interview is in Hebrew.
Dr. Raquel Gardner — Ibogaine for Traumatic Brain Injury & PTSD
Dr. Raquel Gardner is a U.S. board-certified behavioral neurologist, Associate Professor at Tel Aviv University School of Medicine, and Director of Clinical Research at the Joseph Sagol Neuroscience Center, Sheba Medical Center. Her NIH- and DoD-funded research focuses on traumatic brain injury, aging, and neurodegenerative disease — and since October 7, war-related TBI across the full spectrum of severity. GardnerLab · Sheba Medical Center
Whether you are a patient seeking information, a researcher interested in collaboration, a journalist, or someone who simply wants to get involved — we want to hear from you.